Sponsor Pipeline

Istituto Oncologico Veneto IRCCS Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
17
Active Trials
11
Recruiting
10
Disease Areas
7
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-07 NCT07613151
Negative/Low Hormone Receptor and APOcrine Lobular Invasive Breast Carcinoma - A…
Primary endpoint(s) modified
2026-08-07 NCT07613151
Negative/Low Hormone Receptor and APOcrine Lobular Invasive Breast Carcinoma - A…
Trial arms changed: 0 -> 4
2026-08-07 NCT06600568
Novel Therapeutic Approach for Human T-cell Malignancies
date change Primary completion pushed: 2026-07-01 -> 2027-03-01
2026-08-07 NCT06600568
Novel Therapeutic Approach for Human T-cell Malignancies
date change Completion pushed: 2026-07-01 -> 2027-03-01
2026-08-05 NCT07384741
Using Virtual Reality During PICC and PICC-PORT Placement in Cancer Patients
Trial completed
2026-08-05 NCT06595498
Next Generation Sequencing Method for the Detection of EGFR Gene Mutations in the Plasma…
Trial completed
2026-08-05 NCT06595498
Next Generation Sequencing Method for the Detection of EGFR Gene Mutations in the Plasma…
date change Completion pushed: 2026-06-30 -> 2026-07-30
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-08-05 NCT07748221 Healthcare Providers' Attitudes Toward Oncology Patients With Mental Disorders Not Yet Recruiting
Active Trials by Phase
Phase 2
2
Not specified
15
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06275919 Regorafenib for Recurrent Meningioma (MIRAGE Trial) Meningioma, Malignant Recruiting
NCT06155279 Induction Chemo+Immunotherapy in Resectable Epithelioid and Biphasic Pleural Mesothelioma… Pleural Mesothelioma Active, Not Recruiting
Not specified
NCT06273345 OLIGOS: Impact of Treatment on Primary Tumour in Patients With Newly Diagnosed… Oligometastatic Prostate Carcinoma Recruiting
NCT06581549 Immune Microenvironment and Gene Expression Profiling in Mesothelioma Mesothelioma Recruiting
NCT06941194 Preventive Application of Single-use Negative Pressure Wound Therapy (sNPWT) in the… Sarcoma Recruiting
NCT06964815 Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide… Glioblastoma Recruiting
NCT07338292 VIrtual Reality Induced Pain and anxiEty Relief in Outpatient UROlogical Procedures Urologic Diseases Recruiting
NCT06906237 Scarless Advanced Breast Extended Oncoplasty: The ScarABEO Study Breast Cancer Recruiting
NCT06753136 Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary… Primary Visceral Tumors of Any Histotype Recruiting
NCT06245603 A Study to Evaluate Efficacy and Safety of Hydeal Cyst® Intravesical Instillations in… Non-muscle Invasive Bladder Cancer Recruiting
NCT06600568 Novel Therapeutic Approach for Human T-cell Malignancies T-Cell Leukemia/Lymphoma, Adult Recruiting
NCT07613151 Negative/Low Hormone Receptor and APOcrine Lobular Invasive Breast Carcinoma - A… Lobular Breast Carcinoma Recruiting
NCT05267509 An Integrated Radio-immunological Approach Glioma, Malignant Active, Not Recruiting
NCT03449914 The GOLD Study: G8 in OLDer Patients Elderly Metastatic Colorectal Cancer Patients Active, Not Recruiting
NCT03451370 First-line Combination of Capecitabine and Oxaliplatin Plus Bevacizumab in Elderly… Elderly Metastatic Colorectal Cancer Patients Active, Not Recruiting
NCT07185568 IntraOperative UltraSound Guided vs Wire Guided vs Magnetic Seed Guided Breast-Conserving… Breast Cancer Not Yet Recruiting
NCT07748221 Healthcare Providers' Attitudes Toward Oncology Patients With Mental Disorders Stigma of Mental Illness Not Yet Recruiting
Disease Areas
Get alerts when Istituto Oncologico Veneto IRCCS's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free